{"id":152,"date":"2023-12-12T13:47:59","date_gmt":"2023-12-12T13:47:59","guid":{"rendered":"https:\/\/alsbiologics.com\/?page_id=152"},"modified":"2023-12-12T13:49:40","modified_gmt":"2023-12-12T13:49:40","slug":"therapeutic-solutions-international-announces-formation-of-als-biologics-inc-to-commercialize-regenerative-technologies-related-to-dreaded-motor-neuron-disease","status":"publish","type":"page","link":"https:\/\/alsbiologics.com\/index.php\/therapeutic-solutions-international-announces-formation-of-als-biologics-inc-to-commercialize-regenerative-technologies-related-to-dreaded-motor-neuron-disease\/","title":{"rendered":"Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.22.1&#8243; background_color=&#8221;#0C71C3&#8243; background_enable_image=&#8221;off&#8221; custom_padding=&#8221;8vw||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.22.1&#8243; background_enable_image=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; text_font=&#8221;||||||||&#8221; header_font=&#8221;Glegoo|700|||||||&#8221; header_font_size=&#8221;80px&#8221; header_line_height=&#8221;1.3em&#8221; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_direction=&#8221;150deg&#8221; background_color_gradient_stops=&#8221;rgba(0,174,255,0.16) 0%|rgba(29,72,192,0) 100%&#8221; background_color_gradient_start=&#8221;rgba(0,174,255,0.16)&#8221; background_color_gradient_end=&#8221;rgba(29,72,192,0)&#8221; text_orientation=&#8221;right&#8221; background_layout=&#8221;dark&#8221; custom_padding=&#8221;70px|70px|70px|70px|true|true&#8221; custom_padding_tablet=&#8221;40px|40px|40px|40px|true|true&#8221; custom_padding_phone=&#8221;20px|20px|20px|20px|true|true&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;flip&#8221; header_font_size_tablet=&#8221;50px&#8221; header_font_size_phone=&#8221;30px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; box_shadow_style=&#8221;preset1&#8243; box_shadow_vertical=&#8221;40px&#8221; box_shadow_blur=&#8221;200px&#8221; box_shadow_spread=&#8221;-10px&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;]<\/p>\n<h1>ALS Biologics<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;20vw|||&#8221; custom_padding_tablet=&#8221;20px|||&#8221; custom_padding_phone=&#8221;20px|||&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221; padding_tablet=&#8221;20px|||&#8221; padding_last_edited=&#8221;on|phone&#8221; custom_padding__hover=&#8221;|||&#8221; padding_phone=&#8221;20px|||&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_text _builder_version=&#8221;4.22.1&#8243; text_font=&#8221;|600|||||||&#8221; text_font_size=&#8221;16px&#8221; text_line_height=&#8221;1.9em&#8221; background_layout=&#8221;dark&#8221; text_font_size_tablet=&#8221;&#8221; text_font_size_phone=&#8221;14px&#8221; text_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;]<\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: large;\">The ALScell\u2122 (aka JadiCell\u2122) is unique in that it possesses features of mesenchymal stem cells, however, ALScells outperform these cells in terms of a) enhanced growth factor production; b) augmented ability to secrete exosomes; and c) superior angiogenic <br \/>and neurogenic ability.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-2px|auto||auto||&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_text _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-59px|||||&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][\/et_pb_text][et_pb_text _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;]<\/p>\n<header>\n<div>\n<h1 class=\"epi-fontLg bwalignc\" style=\"text-align: center;\"><span style=\"font-size: large;\"><b>Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease<\/b><\/span><\/h1>\n<div class=\"bw-release-subhead\">\n<p class=\"bwalignc\" style=\"text-align: center;\"><span style=\"color: #000000; font-size: large;\"><i>Clinical Stage Stem Cell Company to Expand on Promising Patient Experiences by Launching Subsidiary Company<\/i><\/span><\/p>\n<p class=\"bwalignc\" style=\"text-align: center;\"><span style=\"color: #000000; font-size: large;\"><i><\/i><\/span><\/p>\n<\/div>\n<\/div>\n<\/header>\n<div class=\"bw-release-body  \">\n<div class=\"bw-release-timestamp\"><time datetime=\"2023-12-11T14:00:00Z\" itemprop=\"dateModified\">December 11, 2023 09:00 AM Eastern Standard Time<\/time><\/div>\n<div class=\"bw-release-story\" itemprop=\"articleBody\">\n<p class=\"bwalignl\">ELK CITY, Idaho&#8211;(<span itemprop=\"provider publisher copyrightHolder\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Organization\" itemid=\"https:\/\/www.businesswire.com\"><span itemprop=\"name\"><a referrerpolicy=\"unsafe-url\" rel=\"nofollow\" itemprop=\"url\" href=\"https:\/\/www.businesswire.com\/\">BUSINESS WIRE<\/a><\/span><\/span>)&#8211;Therapeutic Solutions International, Inc. (TSOI), announced today the formation of ALS Biologics Inc, a subsidiary company dedicated to accelerating development of the Company\u2019s assets related to Amyotrophic Lateral Sclerosis, a progressive motor neuron degenerative disease for which no cure exists. The company was formed based on previous positive observations in patients treated with the Company\u2019s ALScell<span>\u2122<\/span> (JadiCell<span>\u2122<\/span>) product under the Right to Try Law.<\/p>\n<p class=\"bwalignl\">\u201cStem cells do not work in isolation. By having had the opportunity to treat numerous patients with neurodegenerative conditions such as ALS in a practical setting, we have learned numerous ways to improve outcome, with practical techniques that we are packaging into this new company dedicated to providing new directions in eventually curing this terrible disease,\u201d said Dr. James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International. \u201cCurrent treatments offer marginal benefit with the average survival time of patients with ALS being two to five years according to the ALS Association<sup>1<\/sup>. This needs to change. We plan to take our current intellectual property and findings and position them in a manner for greater clinical development and accelerated patient access.\u201d<\/p>\n<p>\u201cHaving been coinventor of the numerous intellectual properties amassed in Therapeutic Solutions International, I believe it is important to place certain indications into specific companies in order to facilitate focus and concentration of expertise,\u201d said Thomas Ichim, Ph.D., Interim CEO of ALS Biologics and Board Member of Therapeutic Solutions International.<\/p>\n<p>\u201cI am proud to say that the team at TSOI has truly transformed itself into a medical &#8216;Innovation Factory&#8217; of ideas, patents, and clinical protocols,\u201d stated Timothy Dixon, President, and CEO of Therapeutic Solutions International. \u201cWe anticipate IND filing for treatment of ALS on or before the second quarter of 2024.\u201d<\/p>\n<p><b>About Therapeutic Solutions International, Inc.<\/b><\/p>\n<p>Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company&#8217;s corporate website is <a referrerpolicy=\"unsafe-url\" target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.therapeuticsolutionsint.com&amp;esheet=53868979&amp;newsitemid=20231211583538&amp;lan=en-US&amp;anchor=www.therapeuticsolutionsint.com&amp;index=1&amp;md5=cb6dfd67091f1e9fcb7fc09bbff47256\" rel=\"nofollow noopener\" shape=\"rect\">www.therapeuticsolutionsint.com<\/a>.<\/p>\n<p><b>About ALS Biologics, Inc.<\/b><\/p>\n<p>ALS Biologics is a wholly owned subsidiary of Therapeutic Solutions International. The Company&#8217;s corporate website is <a referrerpolicy=\"unsafe-url\" target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.alsbiologics.com&amp;esheet=53868979&amp;newsitemid=20231211583538&amp;lan=en-US&amp;anchor=www.alsbiologics.com&amp;index=2&amp;md5=970d841aea923dbf59a4647fc2efea90\" rel=\"nofollow noopener\" shape=\"rect\">www.alsbiologics.com<\/a>.<\/p>\n<p>1 <a referrerpolicy=\"unsafe-url\" target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.als.org%2Funderstanding-als%23%3A%7E%3Atext%3DAlthough%2520the%2520mean%2520survival%2520time%2C%252C%2520arms%252C%2520legs%2520or%2520feet.&amp;esheet=53868979&amp;newsitemid=20231211583538&amp;lan=en-US&amp;anchor=Helping+You+Understand+ALS+%7C+The+ALS+Association&amp;index=3&amp;md5=26475a3fca8483add0d412aa4d111b3f\" rel=\"nofollow noopener\" shape=\"rect\">Helping You Understand ALS | The ALS Association<\/a><\/p>\n<\/div>\n<\/div>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ALS BiologicsThe ALScell\u2122 (aka JadiCell\u2122) is unique in that it possesses features of mesenchymal stem cells, however, ALScells outperform these cells in terms of a) enhanced growth factor production; b) augmented ability to secrete exosomes; and c) superior angiogenic and neurogenic ability. Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-152","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/pages\/152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/comments?post=152"}],"version-history":[{"count":3,"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/pages\/152\/revisions"}],"predecessor-version":[{"id":156,"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/pages\/152\/revisions\/156"}],"wp:attachment":[{"href":"https:\/\/alsbiologics.com\/index.php\/wp-json\/wp\/v2\/media?parent=152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}